26107-82-4

Basic information

• Product Name: 3,5-BIS(TRIFLUOROMETHYL)BENZHYDRAZIDE
• Synonyms: 3,5-Bis(trifluoromethyl)benzohydrazide;Benzoic acid, 3,5-bis(trifluoromethyl)-, hydrazide;BUTTPARK 35\03-78;3,5-BIS(TRIFLUOROMETHYL)BENZHYDRAZIDE;3,5-BIS(TRIFLUOROMETHYL)BENZOIC ACID HYDRAZIDE;3,5-DI(TRIFLUOROMETHYL)BENZHYDRAZIDE;3,5-DI(TRIFLUOROMETHYL)BENZOIC ACID HYDRAZIDE;3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOHYDRAZIDE
• CAS NO: 26107-82-4
• Molecular Formula: C₉H₆F₆N₂O
• Molecular Weight: 272.15
• EINECS: 247-462-1
• Mol File: 26107-82-4.mol
• Article Data: 9

Chemical Properties

• Melting Point: 131-135 °C
• Appearance: white crystalline powder
• Density: 1.479 g/cm³
• Refractive Index: 1.442
• PKA: 11.21±0.10(Predicted)
• BRN: 2596448
• CAS DataBase Reference: 3,5-BIS(TRIFLUOROMETHYL)BENZHYDRAZIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-BIS(TRIFLUOROMETHYL)BENZHYDRAZIDE(26107-82-4)
• EPA Substance Registry System: 3,5-BIS(TRIFLUOROMETHYL)BENZHYDRAZIDE(26107-82-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26
• HazardClass: IRRITANT
• Hazardous Substances Data: 26107-82-4(Hazardous Substances Data)

Usage

Chemical Properties

white crystalline powder

InChI:InChI=1/C9H6F6N2O/c10-8(11,12)5-1-4(7(18)17-16)2-6(3-5)9(13,14)15/h1-3H,16H2,(H,17,18)

Upstream product

• 96617-71-9 3,5-bis-trifluoromethylbenzoic acid ethyl ester 
• 26107-80-2 3’,5’-bis(trifluoromethyl)acetophenone 
• 785-56-8 3,5-bis(trifluoromethyl)phenyl carboxylic acid chloride 
• 725-89-3 3,5-bistrifluoromethylbenzoic acid 

Downstream Products

• 1219921-87-5 C₁₄H₁₂F₆N₂O₄ 
• 1221887-42-8 1-[3,5-bis(trifluoromethyl)benzoyl]-2-(4-methoxycarbonylbenzoyl)hydrazine 
• 220381-26-0 5-(3,5-bis(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one 

Relevant articles and documents

AMINO ALCOHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

The present invention belongs to the field of medicine, and specifically discloses an amino alcohol derivative represented by Formula I, a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof. In addition, the present invention also discloses a pharmaceutical composition comprising the above substances, and a use of the substance in the preparation of a medicament for the prevention and treatment of an immune inflammatory disease, or a disease or condition associated with immunological competence such as multiple sclerosis, ALS, CIDP, systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, psoriasis, polymyositis, etc.

Synthesis, fungicidal activity, and 3D-QSAR of tetrazole derivatives containing phenyloxadiazole moieties

In an effort to discover new agents with good fungicidal activities against CDM (cucumber downy mildew), a series of tetrazole derivatives containing phenyloxadiazole moieties were designed and synthesized. The EC50 values for fungicidal activities against CDM were determined. Bioassay results indicated that most synthesized compounds exhibited potential in vivo fungicidal activity against CDM. A CoMFA (comparative molecular field analysis) model based on the bioactivity was developed to identify some primary structural quality for the efficiency. The values of q2 and r2 for the established model were 0.791 and 0.982 respectively, which reliability and predict abilities were verified. Three analogues (q3, q4, q5) were designed and synthesized based on the model. All these compounds exhibited significant fungicidal activity on CDM with the EC50 of 1.43, 1.52, 1.77 mg·L?1. This work could provide a useful instruction for the further structure optimization.

A general and efficient entry to asymmetric tetrazines for click chemistry applications

The importance of click chemistry is widely recognized. Among all the known click reactions, those involving tetrazines represent the fastest click reactions reported and are generating a great deal of interest. However, there is no efficient entry to asymmetric tetrazines and those with strong electron withdrawing groups, which limits the development of this field. Herein, we report a general and efficient entry to asymmetric tetrazines with strongly electron withdrawing groups.